celecoxib has been researched along with Arteriosclerosis in 2 studies
Arteriosclerosis: Thickening and loss of elasticity of the walls of ARTERIES of all sizes. There are many forms classified by the types of lesions and arteries involved, such as ATHEROSCLEROSIS with fatty lesions in the ARTERIAL INTIMA of medium and large muscular arteries.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Celecoxib treatment significantly decreased MCP-1 expression (P < 0." | 5.33 | Celecoxib, a selective cyclooxygenase-2 inhibitor, decreases monocyte chemoattractant protein-1 expression and neointimal hyperplasia in the rabbit atherosclerotic balloon injury model. ( Forudi, F; Keller, BT; Koki, AT; Lincoff, AM; Penn, MS; Smith, ME; Tarakji, K; Topol, EJ; Wang, K; Zhang, M; Zhou, X; Zhou, Z, 2005) |
| "Celecoxib treatment significantly decreased MCP-1 expression (P < 0." | 1.33 | Celecoxib, a selective cyclooxygenase-2 inhibitor, decreases monocyte chemoattractant protein-1 expression and neointimal hyperplasia in the rabbit atherosclerotic balloon injury model. ( Forudi, F; Keller, BT; Koki, AT; Lincoff, AM; Penn, MS; Smith, ME; Tarakji, K; Topol, EJ; Wang, K; Zhang, M; Zhou, X; Zhou, Z, 2005) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bea, F | 1 |
| Blessing, E | 1 |
| Bennett, BJ | 1 |
| Kuo, CC | 1 |
| Campbell, LA | 1 |
| Kreuzer, J | 1 |
| Rosenfeld, ME | 1 |
| Wang, K | 1 |
| Tarakji, K | 1 |
| Zhou, Z | 1 |
| Zhang, M | 1 |
| Forudi, F | 1 |
| Zhou, X | 1 |
| Koki, AT | 1 |
| Smith, ME | 1 |
| Keller, BT | 1 |
| Topol, EJ | 1 |
| Lincoff, AM | 1 |
| Penn, MS | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| [NCT00500279] | Phase 4 | 900 participants (Anticipated) | Interventional | 2006-11-30 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
2 other studies available for celecoxib and Arteriosclerosis
| Article | Year |
|---|---|
Chronic inhibition of cyclooxygenase-2 does not alter plaque composition in a mouse model of advanced unstable atherosclerosis.
Topics: Actins; Animals; Anti-Inflammatory Agents; Apolipoproteins E; Arteriosclerosis; Brachiocephalic Trun | 2003 |
Celecoxib, a selective cyclooxygenase-2 inhibitor, decreases monocyte chemoattractant protein-1 expression and neointimal hyperplasia in the rabbit atherosclerotic balloon injury model.
Topics: Angioplasty, Balloon; Animals; Arteriosclerosis; Celecoxib; Chemokine CCL2; Cyclooxygenase 1; Cycloo | 2005 |